Avalo Therapeutics, Inc. ($AVTX)
Filing Information
| Accession Number | 0001810417-26-000012 |
|---|---|
| Form Type | 4 |
| Filing Date | May 11, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
55,818
Total Value
$632,644.93
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | May 7, 2026 | Exercise/Conversion | 18,606 | $9.88 | $183,827.28 | 19,029 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | May 7, 2026 | Sale | 18,606 | $24.12 | $448,817.65 | 423 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | May 7, 2026 | Exercise/Conversion | 18,606 | $0.00 | $0.00 | 168,094 | Direct | โ | View Details |